Buy Crypto Markets Spot FuturesGOLD Earn Event Center

Entera Bio Ltd. (ENTX)

NASDAQ

$1.29

$--

(0.00%)

Entera Bio Ltd. (ENTX) Live Price Chart

Page last updated: 2026-05-08 13:55:00

Key Market Data

Market Cap	$60.14M
Open	$1.35
High	$10.16
Low	$0.30
Previous Close	$1.37
Price Change	--
Percentage Change	0.00%
Volume	64K

Entera Bio Ltd. (ENTX) Stock Price Today

Entera Bio Ltd. (ENTX) is currently trading at $1.29 as of 2026-05-08 13:55:00, reflecting a 0.00% move ($-0.00) from the previous close.

In the short term, the stock has returned +12.17% over the past four weeks. Over the last 12 months, Entera Bio Ltd. has recorded a -41.89% price change, indicating a Weak performance relative to the broader market.

Entera Bio Ltd. (ENTX) 7-Day Stock Price Changes

Over the past seven days, Entera Bio Ltd. has traded within a short-term range shaped by market sentiment in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. During this period, the stock moved from its previous closing price of $1.13 to the latest recorded price of $1.29, reflecting an intraday change of 0.00%. Daily movements highlight shifts in trading volume (63,870), investor positioning, and reactions to macroeconomic updates.

From a momentum standpoint, ENTX has delivered a +12.17% return over the past month and a -41.89% change in the last 12 months, indicating a Weak trend relative to its broader sector peers.

How to Buy Entera Bio Ltd. (ENTX)

You can buy and trade ENTX on MEXC in three simple steps:

Step 1: Create and Verify Your MEXC Account

Sign up on MEXC and complete the required identity verification (KYC). This ensures full access to trading features and secure funding options.

Step 2: Deposit Funds Into Your Account

Choose your preferred payment method to add USDT or other supported assets to your MEXC wallet. Depositing crypto is the fastest way to get started.

Step 3: Search for ENTX and Execute Your Trade

Open the trading page, enter ENTX in the search bar, select the amount of ENTX you would like to purchase. Place a market order for instant execution or a limit order to buy at your target price.

What is Entera Bio Ltd. (ENTX)?

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to perform. Its product candidates are: EB613, which is being developed as an oral, osteoanabolic (bone-building) tablet treatment for osteoporosis; EB612, being developed as an oral PTH(1-34) tablet peptide replacement therapy for patients with hypoparathyroidism; EB618, an Oral GLP-1 being developed to tackle obesity; and Oral GLP-2, a peptide tablet alternative for patients suffering from short bowel syndrome. The company operates in Israel.

Entera Bio Ltd. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	22
Sector	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Company Website	https://www.enterabio.com

Frequently Asked Questions (FAQ)

1.What is the current share price of Entera Bio Ltd.?

The latest trading price for Entera Bio Ltd. (Common Stock) is $ 1.29, compared with a previous closing price of $ 1.37. That means the stock has moved 0.00% so far today. Intraday price updates and recent trading activity for ENTX can be tracked on the live chart and quote section on this page.

2.Is Entera Bio Ltd. stock going up or down?

Looking at recent performances, ENTX has returned +12.17% over the past month, -57.00% over the last six months and -41.89% over the past year. These figures capture share-price changes only, not the impact of dividends. Together they describe Weak price momentum for Entera Bio Ltd. stock, but keep in mind that past returns do not guarantee future results.

3.Where does ENTX currently sit relative to its 52-week high and low?

In the most recent 52-week period, Entera Bio Ltd. has traded between a low of $ 0.91 and a high of $ 3.22. This 52-week range helps show where today's share price sits relative to its recent highs and lows, and is often used by investors to judge stock volatility, potential support and resistance levels, and whether ENTX is currently nearer the top or the bottom of its one-year trading band.

4.How is Entera Bio Ltd. classified by sector and industry?

Entera Bio Ltd. is classified in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. In practice, this means Entera Bio Ltd. is grouped with other companies that serve similar end-markets and operate under comparable competitive and regulatory conditions. For investors, knowing ENTX’s sector helps with portfolio diversification, peer comparisons, and understanding how broader trends affecting the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector could influence Entera Bio Ltd.’s performance.

5.Where is Entera Bio Ltd. listed and how large is it by market value?

Entera Bio Ltd. is listed on the NASDAQ stock exchange in United States. Based on a market capitalization of $ 60.14M, the company is classified as a Small-cap stock. Market cap gives a quick sense of Entera Bio Ltd.'s size and importance in the equity market and is often used by investors and index providers when constructing portfolios or benchmarks.

6.What does ENTX's EPS tell investors about its profitability?

Trailing-twelve-month EPS of $ -0.21 summarises how much profit Entera Bio Ltd. has generated per share over the last year. Rising EPS over time can signal improving profitability or effective share repurchases, while flat or declining EPS may point to slower growth or margin pressure. EPS is a key input into valuation metrics such as P/E and is often monitored closely around earnings announcements.

7.How can I track Entera Bio Ltd.'s financial performance over time?

To follow Entera Bio Ltd.'s financial performance, investors typically review its quarterly and annual reports, which include detailed income statements, balance sheets and cash-flow statements. Combining these filings with key market data shown on this page—such as share price trends, P/E and dividend yield—provides a more complete view of how ENTX is performing and how the market is responding.

8.When is Entera Bio Ltd. expected to report earnings?

Entera Bio Ltd.'s next scheduled earnings release is currently expected on -- (the date may be updated by the company). Earnings announcements often act as important catalysts for ENTX, as they provide updated information on revenue, profitability and management's outlook.

9.What usually comes out in Entera Bio Ltd.'s earnings reports?

Entera Bio Ltd.'s earnings reports typically include headline figures such as revenue, net income and EPS, along with commentary on segment performance, margins, cash flow and guidance for future periods. Investors compare these results with market expectations and prior periods to assess whether ENTX is meeting, beating or missing expectations.

10.How can I stay informed about Entera Bio Ltd.'s results and guidance?

You can stay up to date on Entera Bio Ltd. by reviewing its quarterly earnings releases, listening to or reading transcripts of earnings calls, and following company news and filings. Pairing this fundamental information with the price and return data for ENTX on this page helps you see how new information is being reflected in the stock.

11.Does Entera Bio Ltd. pay a regular cash dividend to its shareholders?

Entera Bio Ltd. Non-paying. Based on the latest information, the stock has an indicated annual cash dividend of -- per share and a current dividend yield of 0 at the recent share price. Dividends are typically paid --, although the board can change the dividend policy at any time. Income-focused investors often monitor ENTX's dividend level, payment frequency and any announcements about future dividends when assessing the stock's appeal as a dividend-paying investment.

12.What are the current dividend yield and dividend payout ratio for ENTX?

Based on the latest earnings data, ENTX has a dividend yield of 0 and a dividend payout ratio of 0. The dividend yield shows how much cash return an investor receives from dividends each year relative to the current share price, helping assess whether Entera Bio Ltd. is an attractive income stock. The dividend payout ratio measures what percentage of earnings Entera Bio Ltd. distributes to shareholders as dividends versus how much it retains to reinvest in the business, which is an important indicator of dividend sustainability and room for future dividend growth.

13.What kind of business is Entera Bio Ltd.?

Entera Bio Ltd. is a publicly traded company in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) industry within the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. It generates revenue from products and services related to this core business area, and investors can find a detailed description of its operations, strategy and geographic exposure in the company's annual report and other regulatory filings.

14.How is ENTX valued in terms of P/E ratio and EPS?

Entera Bio Ltd. currently trades at a price-to-earnings (P/E) ratio of --, based on trailing-twelve-month earnings per share (EPS) of $ -0.21. P/E is calculated by dividing the share price by EPS and shows how much investors are paying today for each unit of Entera Bio Ltd.'s earnings. Comparing ENTX's P/E and EPS to those of other BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) companies can help investors judge whether its valuation looks rich or attractive.

Explore More US Stocks

Largest Market Cap

See US stocks with the highest market capitalization

Most Actively Traded

Discover today's most actively traded US stocks

SkyWater Technology, Inc.

Shuttle Pharmaceuticals Holdings, Inc.

SHPH

Bandwidth Inc.

BAND

Top Gainers

Browse today's leading gainers in the US stock market

Robo.ai Inc.

AIIO

Antelope Enterprise Holdings Limited

AEHL

Fluence Energy, Inc.

FLNC

Fundrise Innovation Fund, LLC

VCX

Traws Pharma, Inc.

TRAW

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

BTC

ETH

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

ENTX-to-USD Calculator

Amount

ENTX

USD

1 ENTX = 1.29 USD